Literature DB >> 19846521

Pathogenesis of hepatitis C virus infection in Tupaia belangeri.

Yutaka Amako1, Kyoko Tsukiyama-Kohara, Asao Katsume, Yuichi Hirata, Satoshi Sekiguchi, Yoshimi Tobita, Yukiko Hayashi, Tsunekazu Hishima, Nobuaki Funata, Hiromichi Yonekawa, Michinori Kohara.   

Abstract

The lack of a small-animal model has hampered the analysis of hepatitis C virus (HCV) pathogenesis. The tupaia (Tupaia belangeri), a tree shrew, has shown susceptibility to HCV infection and has been considered a possible candidate for a small experimental model of HCV infection. However, a longitudinal analysis of HCV-infected tupaias has yet to be described. Here, we provide an analysis of HCV pathogenesis during the course of infection in tupaias over a 3-year period. The animals were inoculated with hepatitis C patient serum HCR6 or viral particles reconstituted from full-length cDNA. In either case, inoculation caused mild hepatitis and intermittent viremia during the acute phase of infection. Histological analysis of infected livers revealed that HCV caused chronic hepatitis that worsened in a time-dependent manner. Liver steatosis, cirrhotic nodules, and accompanying tumorigenesis were also detected. To examine whether infectious virus particles were produced in tupaia livers, naive animals were inoculated with sera from HCV-infected tupaias, which had been confirmed positive for HCV RNA. As a result, the recipient animals also displayed mild hepatitis and intermittent viremia. Quasispecies were also observed in the NS5A region, signaling phylogenic lineage from the original inoculating sequence. Taken together, these data suggest that the tupaia is a practical animal model for experimental studies of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19846521      PMCID: PMC2798454          DOI: 10.1128/JVI.01448-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

Review 2.  The molecular virology of hepatitis C.

Authors:  M E Major; S M Feinstone
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

3.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

4.  The Convention on International Trade in Endangered Species of Wild Fauna and Flora.

Authors:  E I Goldsmith
Journal:  J Med Primatol       Date:  1978       Impact factor: 0.667

5.  Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees.

Authors:  Z Hong; M Beaudet-Miller; R E Lanford; B Guerra; J Wright-Minogue; A Skelton; B M Baroudy; G R Reyes; J Y Lau
Journal:  Virology       Date:  1999-03-30       Impact factor: 3.616

7.  Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.

Authors:  E Walter; R Keist; B Niederöst; I Pult; H E Blum
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

8.  Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma.

Authors:  Xinping Xu; Hongbo Chen; Xiaomei Cao; Kunlong Ben
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

9.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.

Authors:  Michael Thomson; Michelina Nascimbeni; Michael B Havert; Marian Major; Sophia Gonzales; Harvey Alter; Stephen M Feinstone; Krishna K Murthy; Barbara Rehermann; T Jake Liang
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  48 in total

1.  Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Authors:  Xiao-Ling Zhou; Gareth J Sullivan; Pingnan Sun; In-Hyun Park
Journal:  Arch Pharm Res       Date:  2012-02-28       Impact factor: 4.946

2.  Research technique: the murine candidate.

Authors:  Elie Dolgin
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

3.  Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Authors:  Qiang Ding; Markus von Schaewen; Gabriela Hrebikova; Brigitte Heller; Lisa Sandmann; Mario Plaas; Alexander Ploss
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 4.  Animal models for the study of hepatitis C virus infection and replication.

Authors:  Kristin L MacArthur; Catherine H Wu; George Y Wu
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

5.  Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Authors:  Yimin Tong; Yongzhe Zhu; Xueshan Xia; Yuan Liu; Yue Feng; Xian Hua; Zhihui Chen; Hui Ding; Li Gao; Yongzhi Wang; Mark A Feitelson; Ping Zhao; Zhong-Tian Qi
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Gene therapeutic approach for inhibiting hepatitis C virus replication using a recombinant protein that controls interferon expression.

Authors:  Chul Hyun Joo; Uk Lee; Young Ran Nam; Jae U Jung; Heuiran Lee; Young Keol Cho; Yoo Kyum Kim
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

Review 7.  The tree shrew as a model for infectious diseases research.

Authors:  Runfeng Li; Mark Zanin; Xueshan Xia; Zifeng Yang
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 8.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Animal models for the study of HCV.

Authors:  Koen Vercauteren; Ype P de Jong; Philip Meuleman
Journal:  Curr Opin Virol       Date:  2015-05-23       Impact factor: 7.090

10.  Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus.

Authors:  Anuj Kumar; Asit Kumar Manna; Upasana Ray; Ranajoy Mullick; Gautam Basu; Saumitra Das; Siddhartha Roy
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.